EX-99.1 2 c04052exv99w1.htm EXHIBIT 99.1 Exhibit 99.1
Exhibit 99.1
(NATIONWIDE HEALTH PROPERTIES LOGO)
NATIONWIDE HEALTH PROPERTIES, INC.
REPORTS 2010 SECOND QUARTER RESULTS
   
Completed $194 Million of Investments in the Second Quarter of 2010
 
   
Raising FFO Guidance on the High End of the Range by $0.08 per Share to $2.25
 
   
Second Quarter 2010 Revenue Increased 13% Over Second Quarter 2009
NEWPORT BEACH, CA, —(Marketwire– August 2, 2010) — Nationwide Health Properties, Inc. (NYSE: NHP) today announced results of operations for the second quarter ended June 30, 2010. Contemporaneously with this press release, the Company filed its Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2010 with the Securities and Exchange Commission.
“We maintained the first quarter momentum with $194 million of investments in the second quarter. The initial yield on the $578 million of investments made in the first six months of the year is 8.5%,” commented Douglas M. Pasquale, NHP’s Chairman and Chief Executive Officer. “Our liquidity position remains strong with $173 million in cash at quarter end and the extension of the maturity date of our $700 million credit facility to December 15, 2011. NHP’s outstanding credit statistics and available capital facilitate our ability to add accretive investments in the coming quarters,” Mr. Pasquale added.

 

 


 

SECOND QUARTER 2010 RESULTS OF OPERATIONS
The following table presents selected unaudited financial information for the second quarter and six months ended June 30, 2010 as compared to the same periods of 2009:
Selected Financial Data
($ in thousands, except per share amounts)
                                 
    Three Months Ended June 30,  
    2010     2009     $ Change     % Change  
 
                               
Revenue
  $ 109,248     $ 96,769     $ 12,479       12.9 %
Income from Continuing Operations
  $ 33,011     $ 34,542     $ (1,531 )     -4.4 %
Net Income Attributable to NHP Common Stockholders
  $ 37,169     $ 33,299     $ 3,870       11.6 %
Net Income Attributable to NHP Common Stockholders Per Diluted Share
  $ 0.30     $ 0.31     $ (0.01 )     -3.2 %
Diluted FFO
  $ 68,072     $ 66,630     $ 1,442       2.2 %
Adjusted Diluted FFO
  $ 69,699     $ 62,066     $ 7,633       12.3 %
Diluted FFO Per Share
  $ 0.55     $ 0.61     $ (0.06 )     -9.8 %
Adjusted Diluted FFO Per Share
  $ 0.57     $ 0.57     $       0.0 %
Diluted FAD
  $ 66,327     $ 66,242     $ 85       0.1 %
Adjusted Diluted FAD
  $ 67,954     $ 61,678     $ 6,276       10.2 %
Diluted FAD Per Share
  $ 0.54     $ 0.61     $ (0.07 )     -11.5 %
Adjusted Diluted FAD Per Share
  $ 0.55     $ 0.57     $ (0.02 )     -3.5 %
                                 
    Six Months Ended June 30,  
    2010     2009     $ Change     % Change  
 
                               
Revenue
  $ 211,443     $ 193,477     $ 17,966       9.3 %
Income from Continuing Operations
  $ 64,073     $ 63,673     $ 400       0.6 %
Net Income Attributable to NHP Common Stockholders
  $ 68,598     $ 82,453     $ (13,855 )     -16.8 %
Net Income Attributable to NHP Common Stockholders Per Diluted Share
  $ 0.56     $ 0.78     $ (0.22 )     -28.2 %
Diluted FFO
  $ 132,263     $ 128,197     $ 4,066       3.2 %
Adjusted Diluted FFO
  $ 134,638     $ 123,633     $ 11,005       8.9 %
Diluted FFO Per Share
  $ 1.09     $ 1.18     $ (0.09 )     -7.6 %
Adjusted Diluted FFO Per Share
  $ 1.11     $ 1.14     $ (0.03 )     -2.6 %
Diluted FAD
  $ 130,594     $ 127,668     $ 2,926       2.3 %
Adjusted Diluted FAD
  $ 132,969     $ 123,104     $ 9,865       8.0 %
Diluted FAD Per Share
  $ 1.08     $ 1.18     $ (0.10 )     -8.5 %
Adjusted Diluted FAD Per Share
  $ 1.10     $ 1.14     $ (0.04 )     -3.5 %

 

2


 

NON-GAAP FINANCIAL MEASURES
Diluted Funds From Operations (“FFO”) and Diluted Funds Available for Distribution (“FAD”) are non-GAAP measures that we believe are important to understanding our operations. We believe diluted FFO is an important supplemental measure of operating performance because it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). We believe diluted FAD is an important supplemental measure of operating performance because, like diluted FFO, it excludes the effects of depreciation and amortization and gains (losses) from sales of facilities (both of which are based on historical costs and which may be of limited relevance in evaluating current performance). It also excludes straight-lined rent and other non-cash items that have become more significant for us and our competitors over the last several years. We believe that net income is the most directly comparable GAAP measure to diluted FFO and diluted FAD. Reconciliations between net income and diluted FFO and net income and diluted FAD are included in the accompanying financial data. For guidance, we have also included in the accompanying financial data reconciliations between net income per share and diluted FFO and diluted FAD per share. We have also included adjusted diluted FFO and adjusted diluted FAD amounts which exclude acquisition costs and the recognition of a net gain on re-measurement of equity interest upon acquisition in 2010 and gains on debt extinguishments in 2010 and 2009.
SECOND QUARTER 2010 INVESTMENT ACTIVITY
Investment Activity 2010
($ in thousands)
                                 
    Q1     Q2     Q3     YTD  
Investment   Total     Total     To Date     Total  
Assisted and Independent Living Facilities
                               
Number
            5       2       7  
Investment
          $ 6,000     $ 31,000     $ 37,000  
Initial Yield
            8.8 %     8.0 %     8.1 %
 
                               
Skilled Nursing Facilities
                               
Number
            11       4       15  
Investment
          $ 130,000     $ 29,000     $ 159,000  
Initial Yield
            9.1 %     9.8 %     9.2 %
 
                               
Medical Office Buildings
                               
Number
    33       8               41  
Investment
  $ 380,000     $ 46,000             $ 426,000  
Initial Yield
    8.2 %     9.3 %             8.4 %
 
                               
Total
                               
Number
    33       24       6       63  
Investment
  $ 380,000     $ 182,000     $ 60,000     $ 622,000  
Initial Yield
    8.2 %     9.1 %     8.9 %     8.5 %
Additionally in the second quarter of 2010, we invested approximately $6.0 million in revenue producing capital expenditures at a blended yield of 8.4% for a total of $10.0 million at a blended yield of 8.4% in the first six months of the year, and funded two unsecured loans totaling $5.5 million at a blended rate of 9.3%.

 

3


 

SECOND QUARTER 2010 FINANCING TRANSACTIONS
At-The-Market Equity Offering Program 2010
(in thousands, except price per share)
                                 
    Q1     Q2     Q3     YTD  
    Total     Total     To Date     Total  
 
                               
Number of Shares
    1,269       3,789       1,655       6,713  
Average Price per Share
  $ 35.58     $ 35.69     $ 37.03     $ 36.00  
Net Proceeds
  $ 44,673     $ 133,820     $ 60,644     $ 239,137  
In June 2010, we exercised our option to extend our $700 million credit facility maturity to December 15, 2011.
Subsequent to June 30, 2010, we paid off $64.3 million of mortgage debt that matured.
2010 GUIDANCE
Guidance for Year Ended December 31, 2010
                                 
    Guidance Dates     Change from  
    Initial     Q1 Results     Current     Previous  
Metric   Guidance     Update     Update     Update  
Adjusted Diluted FFO Per Share
                               
High End
  $ 2.09     $ 2.17     $ 2.25     $ 0.08  
Low End
  $ 2.05     $ 2.14     $ 2.23     $ 0.09  
 
                               
Adjusted Diluted FAD Per Share
                               
High End
  $ 2.05     $ 2.13     $ 2.19     $ 0.06  
Low End
  $ 2.01     $ 2.10     $ 2.17     $ 0.07  
Our guidance includes shares issued through our at-the-market equity offering program, mortgage debt payoffs and closed acquisitions and dispositions through August 2, 2010 and excludes any other acquisitions, investments, impairments or capital transactions that may occur in the remainder of 2010.

 

4


 

CONFERENCE CALL INFORMATION
We have scheduled a conference call and webcast on Tuesday, August 3, 2010 at 11:00 a.m. Pacific Time (2:00 p.m. Eastern Time) to discuss these results. The conference call is accessible by dialing 800-573-4752 and referencing conference ID number 96821760 or by logging on to our website at http://www.nhp-reit.com. The international dial-in number is 617-224-4324. The earnings release and any additional financial information that may be discussed on the conference call and webcast will also be available at the same location on our website. A digitized replay of the conference call will be available from 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) that day until 9:00 p.m. Pacific Time (Midnight Eastern Time) on September 3, 2010. Callers can access the replay by dialing 888-286-8010 or 617-801-6888 and entering conference ID number 78550756. Webcast replays will also be available on our website for at least 12 months following the conference call. Our supplemental information package for the quarter ended June 30, 2010 is available on our website, free of charge, at http://www.nhp-reit.com by selecting “Investor Relations” followed by “Financial Information” and is included in our Current Report on Form 8-K filed August 2, 2010 with the SEC also containing this release. Shareholders may receive free of charge a complete set of our audited financial statements upon request.
ABOUT NATIONWIDE HEALTH PROPERTIES, INC.
Nationwide Health Properties, Inc. is a real estate investment trust (REIT) that invests primarily in healthcare real estate in the United States. As of June 30, 2010, the Company’s portfolio of properties, including mortgage loans and properties owned by unconsolidated joint ventures, totaled 628 properties among the following segments: 283 senior housing facilities, 206 skilled nursing facilities, 120 medical office buildings, 11 continuing care retirement communities, 7 specialty hospitals and 1 asset held for sale. For more information on Nationwide Health Properties, Inc., visit our website at http://www.nhp-reit.com.
FORWARD LOOKING STATEMENTS
Certain information contained in this release includes forward-looking statements. Forward-looking statements include statements regarding our expectations, beliefs, intentions, plans, objectives, goals, strategies, future events or performance and underlying assumptions and other statements which are not statements of historical facts. These statements may be identified, without limitation, by the use of forward-looking terminology such as “may,” “will,” “anticipates,” “expects,” “believes,” “intends,” “should” or comparable terms or the negative thereof. These forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those described in the statements. Risks and uncertainties associated with our business include (without limitation) the following: deterioration in the operating results or financial condition, including bankruptcies, of our tenants; non-payment or late payment of rent, interest or loan principal amounts by our tenants; our reliance on one tenant for a significant percentage of our revenue; occupancy levels at certain facilities; our level of indebtedness; changes in the ratings of our debt securities; maintaining compliance with our debt covenants; access to the capital markets and the cost and availability of capital; the effect of healthcare reform legislation or government regulations, including changes in the reimbursement levels under the Medicare and Medicaid programs; the general distress of the healthcare industry; increasing competition in our business sector; the effect of economic and market conditions and changes in interest rates; the amount and yield of any additional investments; risks associated with acquisitions, including our ability to identify and complete favorable transactions, delays or failures in obtaining third party consents or approvals, the failure to achieve perceived benefits,

 

5


 

unexpected costs or liabilities and potential litigation; the ability of our tenants to pay contractual rent and/or interest escalations in future periods; the ability of our tenants to obtain and maintain adequate liability and other insurance; our ability to attract new tenants for certain facilities; our ability to sell certain facilities for their book value; our ability to retain key personnel; potential liability under environmental laws; the possibility that we could be required to repurchase some of our senior notes; changes in or inadvertent violations of tax laws and regulations and other factors that can affect our status as a real estate investment trust; and other factors discussed from time to time in our news releases, public statements and/or filings with the Securities and Exchange Commission, especially the “Risk Factors” sections of our Annual and Quarterly Reports on Forms 10-K and 10-Q. Forward-looking information is provided by us pursuant to the safe harbor established under the Private Securities Litigation Reform Act of 1995 and should be evaluated in the context of these factors. We disclaim any intent or obligation to update these forward-looking statements.
Contact:
Abdo H. Khoury
Chief Financial and Portfolio Officer
Nationwide Health Properties, Inc.
(949) 718-4400
***Financial Tables to Follow***

 

6


 

NATIONWIDE HEALTH PROPERTIES, INC.
CONSOLIDATED INCOME STATEMENTS
(In thousands, except per share data)
(Unaudited)
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2010     2009     2010     2009  
Revenue:
                               
Triple-net lease rent
  $ 76,236     $ 72,674     $ 149,783     $ 145,961  
Medical office building operating rent
    27,124       17,437       48,809       34,523  
 
                       
 
    103,360       90,111       198,592       180,484  
Interest and other income
    5,888       6,658       12,851       12,993  
 
                       
 
    109,248       96,769       211,443       193,477  
Expenses:
                               
Interest expense
    24,452       23,247       48,042       47,319  
Depreciation and amortization
    33,832       30,617       65,723       61,370  
General and administrative
    7,384       6,973       14,369       13,904  
Acquisition costs
    1,627             3,070        
Medical office building operating expenses
    10,270       7,128       18,917       13,962  
 
                       
 
    77,565       67,965       150,121       136,555  
 
                       
Operating income
    31,683       28,804       61,322       56,922  
Income from unconsolidated joint ventures
    1,328       1,174       2,676       2,187  
Gain on debt extinguishment
          4,564       75       4,564  
 
                       
Income from continuing operations
    33,011       34,542       64,073       63,673  
Discontinued operations:
                               
Gains on sale of facilities, net
    3,779             3,801       21,152  
Income from discontinued operations
    232       284       387       634  
 
                       
 
    4,011       284       4,188       21,786  
 
                       
Net income
    37,022       34,826       68,261       85,459  
Net loss (income) attributable to noncontrolling interests
    147       (75 )     337       (102 )
 
                       
Net income attributable to NHP
    37,169       34,751       68,598       85,357  
Preferred stock dividends
          (1,452 )           (2,904 )
 
                       
Income available to NHP common stockholders
  $ 37,169     $ 33,299     $ 68,598     $ 82,453  
 
                       
 
                               
Basic earnings per share (EPS):
                               
Income from continuing operations attributable to NHP common stockholders
  $ 0.28     $ 0.32     $ 0.54     $ 0.59  
Discontinued operations attributable to NHP common stockholders
    0.03             0.03       0.21  
 
                       
Net income attributable to NHP common stockholders
  $ 0.31     $ 0.32     $ 0.57     $ 0.80  
 
                       
 
                               
Diluted EPS:
                               
Income from continuing operations attributable to NHP common stockholders
  $ 0.27     $ 0.31     $ 0.53     $ 0.57  
Discontinued operations attributable to NHP common stockholders
    0.03             0.03       0.21  
 
                       
Net income attributable to NHP common stockholders
  $ 0.30     $ 0.31     $ 0.56     $ 0.78  
 
                       
 
                               
Weighted average shares outstanding for EPS:
                               
Basic
    119,883       103,089       118,473       102,724  
 
                       
Diluted
    122,599       105,182       121,039       104,797  
 
                       

 

7


 

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
(Unaudited)
Reconciliation of Net Income to Adjusted Diluted FFO
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2010     2009     2010     2009  
 
                               
Net income
  $ 37,022     $ 34,826     $ 68,261     $ 85,459  
Preferred stock dividends
          (1,452 )           (2,904 )
Net loss (income) attributable to noncontrolling interests
    147       (75 )     337       (102 )
Real estate related depreciation and amortization
    33,501       30,567       65,046       61,374  
Depreciation in income from unconsolidated joint ventures
    1,181       1,312       2,420       2,618  
Gains on sale of facilities, net
    (3,779 )           (3,801 )     (21,152 )
 
                       
FFO available to NHP common stockholders
    68,072       65,178       132,263       125,293  
Series B preferred dividend add-back
          1,452             2,904  
 
                       
Diluted FFO
    68,072       66,630       132,263       128,197  
Acquisition costs
    1,627             3,070        
Gain on extinguishment of debt
          (4,564 )     (75 )     (4,564 )
Gain on re-measurement of equity interest upon acquisition, net
                (620 )      
 
                       
Adjusted diluted FFO
  $ 69,699     $ 62,066     $ 134,638     $ 123,633  
 
                       
 
                               
Weighted average shares outstanding for diluted FFO:
                               
Diluted weighted average shares outstanding (1)
    122,701       105,241       121,146       104,848  
Series B preferred stock conversion add-back if not already converted
          3,368       154       3,363  
 
                       
Fully diluted weighted average shares outstanding
    122,701       108,609       121,300       108,211  
 
                       
 
                               
Diluted FFO per share
  $ 0.55     $ 0.61     $ 1.09     $ 1.18  
 
                       
Adjusted diluted FFO per share
  $ 0.57     $ 0.57     $ 1.11     $ 1.14  
 
                       
 
                               
Dividends declared per common share
  $ 0.45     $ 0.44     $ 0.89     $ 0.88  
 
                       
 
                               
Adjusted diluted FFO payout ratio
    79 %     77 %     80 %     77 %
 
                       
Adjusted diluted FFO coverage
    1.27       1.30       1.25       1.30  
 
                       
     
(1)  
Diluted weighted average shares outstanding includes the effect of all participating and non-participating share-based payment awards which for us consists of stock options and other share-based payment awards if the effect is dilutive. The dilutive effect of all share-based payment awards is calculated using the treasury stock method. Additionally, our redeemable OP units are included as if converted to common stock on a one-for-one basis.

 

8


 

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATIONS OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
(Unaudited)
Reconciliation of Net Income to Adjusted Diluted FAD
                                 
    Three Months Ended June 30,     Six Months Ended June 30,  
    2010     2009     2010     2009  
 
                               
Net income
  $ 37,022     $ 34,826     $ 68,261     $ 85,459  
Preferred stock dividends
          (1,452 )           (2,904 )
Net loss (income) attributable to noncontrolling interests
    147       (75 )     337       (102 )
Real estate related depreciation and amortization
    33,501       30,567       65,046       61,374  
Gains on sale of facilities, net
    (3,779 )           (3,801 )     (21,152 )
Straight-lined rent
    (3,511 )     (1,599 )     (5,198 )     (3,188 )
Amortization of intangible assets and liabilities
    150       (48 )     91       (271 )
Non-cash stock-based compensation expense
    1,832       1,837       3,426       3,410  
Deferred financing cost amortization
    829       756       1,674       1,570  
Lease commissions and tenant and capital improvements
    (1,066 )     (1,343 )     (1,703 )     (2,069 )
Unconsolidated joint ventures:
                               
Real estate related depreciation and amortization
    1,181       1,312       2,420       2,618  
Straight-lined rent
    (1 )     (12 )     (2 )     (23 )
Deferred finance cost amortization
    22       21       43       42  
 
                       
FAD available to NHP common stockholders
    66,327       64,790       130,594       124,764  
Series B preferred dividends
          1,452             2,904  
 
                       
Diluted FAD
    66,327       66,242       130,594       127,668  
Acquisition costs
    1,627             3,070        
Gain on extinguishment of debt
          (4,564 )     (75 )     (4,564 )
Gain on re-measurement of equity interest upon acquisition, net
                (620 )      
 
                       
Adjusted diluted FAD
  $ 67,954     $ 61,678     $ 132,969     $ 123,104  
 
                       
 
                               
Weighted average shares outstanding for diluted FAD:
                               
Diluted weighted average shares outstanding (1)
    122,701       105,241       121,146       104,848  
Series B preferred stock add-back if not already converted
          3,368       154       3,363  
 
                       
Fully diluted weighted average shares outstanding
    122,701       108,609       121,300       108,211  
 
                       
 
                               
Diluted FAD per share
  $ 0.54     $ 0.61     $ 1.08     $ 1.18  
 
                       
Adjusted diluted FAD per share
  $ 0.55     $ 0.57     $ 1.10     $ 1.14  
 
                       
 
                               
Dividends declared per common share
  $ 0.45     $ 0.44     $ 0.89     $ 0.88  
 
                       
 
                               
Adjusted diluted FAD payout ratio
    82 %     77 %     81 %     77 %
 
                       
Adjusted diluted FAD coverage
    1.22       1.30       1.24       1.30  
 
                       
     
(1)  
Diluted weighted average shares outstanding includes the effect of all participating and non-participating share-based payment awards which for us consists of stock options and other share-based payment awards if the effect is dilutive. The dilutive effect of all share-based payment awards is calculated using the treasury stock method. Additionally, our redeemable OP units are included as if converted to common stock on a one-for-one basis.

 

9


 

NATIONWIDE HEALTH PROPERTIES, INC.
RECONCILIATION OF NET INCOME TO NON-GAAP FINANCIAL MEASURES
(In thousands, except per share data)
2010 Guidance Reconciliation of Net Income to Adjusted Diluted FFO and FAD Per Share
                 
    Year Ended December 31, 2010  
    Guidance  
    Low     High  
 
       
Net income
  $ 153,069     $ 155,568  
Preferred stock dividends
           
Real estate related depreciation and amortization
    127,737       127,737  
Depreciation in income from unconsolidated joint ventures
    4,766       4,766  
Net income attributable to noncontrolling interests
    (282 )     (282 )
Gains on sales of facilities, net
    (10,783 )     (10,783 )
 
           
FFO available to common stockholders
    274,507       277,006  
Series B preferred dividends
           
 
           
Diluted FFO
    274,507       277,006  
Acquisition costs
    3,070       3,070  
Gain on extinguishment of debt
    (75 )     (75 )
Gain on re-measurement of equity interest upon acquisition, net
    (620 )     (620 )
 
           
Adjusted Diluted FFO
    276,882       279,381  
Straight-lined rent
    (10,784 )     (10,784 )
Amortization of intangible assets and liabilities
    (60 )     (60 )
Non-cash stock-based compensation expense
    6,852       6,852  
Deferred financing cost amortization
    3,210       3,210  
Lease commissions and tenant and capital improvements
    (6,407 )     (6,407 )
Unconsolidated Joint Ventures:
               
Straight-lined rent
    (1 )     (1 )
Deferred financing cost amortization
    85       85  
 
           
Adjusted Diluted FAD
  $ 269,777     $ 272,276  
 
           
 
               
Diluted FFO per share
  $ 2.21     $ 2.23  
 
           
Adjusted Diluted FFO per share
  $ 2.23     $ 2.25  
 
           
Adjusted Diluted FAD per share
  $ 2.17     $ 2.19  
 
           
 
               
Weighted average shares outstanding:
               
Diluted weighted average shares outstanding
    121,921       121,921  
NHP/PMB OP units
    2,135       2,135  
 
           
Total
    124,056       124,056  
 
           

 

10


 

NATIONWIDE HEALTH PROPERTIES, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands)
                 
    June 30,     December 31,  
    2010     2009  
    (unaudited)          
Assets
               
Investments in real estate:
               
Land
  $ 329,203     $ 318,457  
Buildings and improvements
    3,505,002       3,088,183  
 
           
 
    3,834,205       3,406,640  
Less accumulated depreciation
    (630,394 )     (585,294 )
 
           
 
    3,203,811       2,821,346  
Mortgage loans receivable, net
    200,241       110,613  
Mortgage loan receivable from related party
          47,500  
Investments in unconsolidated joint ventures
    46,469       51,924  
 
           
Net real estate related investments
    3,450,521       3,031,383  
Cash and cash equivalents
    172,570       382,278  
Receivables, net
    7,888       6,605  
Asset held for sale
    5,601        
Intangible assets
    147,943       93,657  
Other assets
    152,403       133,152  
 
           
Total assets
  $ 3,936,926     $ 3,647,075  
 
           
 
               
Liabilities and Equity
               
Unsecured senior credit facility
  $     $  
Senior notes
    991,633       991,633  
Notes and bonds payable
    533,525       431,456  
Accounts payable and accrued liabilities
    133,447       132,915  
 
           
Total liabilities
    1,658,605       1,556,004  
 
               
Redeemable OP unitholder interests
    78,898       57,335  
 
               
Equity:
               
NHP stockholders’ equity:
               
Series B convertible preferred stock
          51,364  
Common stock
    12,213       11,432  
Capital in excess of par value
    2,360,735       2,128,843  
Cumulative net income
    1,773,877       1,705,279  
Accumulated other comprehensive loss
    (2,477 )     (823 )
Cumulative dividends
    (1,969,571 )     (1,862,996 )
 
           
Total NHP stockholders’ equity
    2,174,777       2,033,099  
Noncontrolling interests
    24,646       637  
 
           
Total equity
    2,199,423       2,033,736  
 
           
Total liabilities and equity
  $ 3,936,926     $ 3,647,075  
 
           

 

11